Menu

Medtronic plc MDT

Full chart Compare
Set alert

Price alert · MDT

All alert types
101.80 USD -3.04 (-2.90%)

At closeNov 6, 2026, 7:33 PM EST

101.23 -0.57 -0.56%

After hours · Nov 6, 7:33 PM ET

100.80 Day range 103.07
73.75 52-week range 105.35
YTD
+5.98%
1 year
+13.04%

Revenue & Expenses

Revenue by
Cardiac and Vascular Group → Revenue: $13.98BRevenue → Gross Profit: $23.64BGross Profit → Net Income: $4.80BGross Profit → Selling, General & Admin: $11.78BGross Profit → Research & Development: $2.87BRevenue → Cost of Revenue: $12.72BGross Profit → Other Operating Expenses: $2.52BGross Profit → Other Expenses: $365.00MGross Profit → Income Tax: $1.30BNeuroscience Group → Revenue: $10.29BMedical Surgical → Revenue: $8.81BDiabetes Group → Revenue: $3.11BGross Profit$23.64BCost of Revenue$12.72BNet Income$4.80BSelling, General & Admin$11.78BResearch & Development$2.87BOther Operating Expenses$2.52BOther Expenses$365.00MIncome Tax$1.30BRevenue$36.36BCardiac and Vascular Group$13.98BNeuroscience Group$10.29BMedical Surgical$8.81BDiabetes Group$3.11B

Latest period ending Apr 24, 2026 · select a line to chart its full history

MDT annual income statement
Fiscal yearFY 2026 Apr 24, 2026FY 2025 Apr 25, 2025FY 2024 Apr 26, 2024FY 2023 Apr 28, 2023FY 2022 Apr 29, 2022
36.36B33.54B32.36B31.23B31.69B
23.64B21.91B21.15B20.51B21.54B
6.47B5.96B5.14B5.49B5.75B
4.80B4.66B3.68B3.76B5.04B
3.733.612.762.823.73
MDT annual balance sheet
Fiscal yearFY 2026 Apr 24, 2026FY 2025 Apr 25, 2025FY 2024 Apr 26, 2024FY 2023 Apr 28, 2023FY 2022 Apr 29, 2022
1.95B2.22B1.28B1.54B3.71B
93.03B91.68B89.98B90.95B90.98B
42.96B43.42B39.56B39.28B38.26B
27.96B28.52B25.02B24.36B24.11B
49.46B48.02B50.21B51.48B52.55B
MDT annual cash flow
Fiscal yearFY 2026 Apr 24, 2026FY 2025 Apr 25, 2025FY 2024 Apr 26, 2024FY 2023 Apr 28, 2023FY 2022 Apr 29, 2022
7.33B7.04B6.79B6.04B7.35B
-2.93B-1.94B-2.37B-3.49B-1.66B
-4.75B-4.36B-4.45B-4.96B-5.34B
-1.90B-1.86B-1.59B-1.46B-1.37B
-269.00M934.00M-259.00M-2.17B121.00M